Table 1.
Author/year | Ref. | Age | Origin | Stage | Adjuvant therapy | Prognosis |
---|---|---|---|---|---|---|
Maeyama (1983) | [3] | 51 | Mature cystic teratoma | Ib | Carboquone + Futraful | Died 6 months |
Iwaoki (1994) | [2] | 57 | Mature cystic teratoma | Ia | CDDP + Epi + CPA | Alive well 3 years |
Hsu (1996) | [5] | 49 | Mature cystic teratoma | I | NR | Alive well 11 months |
Karateke (2006) | [6] | 40 | Mature cystic teratoma | Ic | No therapy | Recurrence 12 months |
Moguel (1992) | [7] | 50 | Endometriosis | IIIc | CDDP + 5-Fu | NR |
Terada (2009) | [4] | 38 | Endometriosis | NR | NR | NR |
Terada (2009) | [4] | 53 | Endometriosis | NR | NR | NR |
Lee (2010) | [1] | 32 | PureASC | IV | PTX-CBDCA | Died 3 months |
Oue case | 57 | Endometrioid adenocarcinoma | Ic | PTX-CBDCA | Alive well 5.5 years |
ASC adenosquamous carcinoma, PTX Paclitaxel, CBDCA Carboplatin, CDDP Cisplatin, Epi Epirubicin, CPA Cyclophosphamide, NR Not recorded